84 – Case Study: Manufacturing a Complex Molecule (S6E9)

We all know what a pill looks like, right? Small,
kind of unassuming. But I bet most people don't
think twice about what it actually takes to make
that medicine, to manufacture it on a large enough
scale so it can actually help people. So pretty
amazing when you think about it. There's so much
science and engineering involved. It's a crazy
puzzle to solve. It is. And we love to... dig
into these things and find those aha moments.
So today, we are going deep on a real -world
example, straight from the world of pharmaceuticals.
We're going to see how scientists and engineers
took on this really intricate challenge of producing
a complex molecule, but in large quantities.
Exactly. We're basically getting a behind -the
-scenes look at how pharmaceutical process research
and development works. OPRND. OPRND, yeah. Think
of it like this. You have this promising molecule,
right? It's discovered in the lab and then it
has to make this huge leap. It starts as this
tiny little sample and somehow it's got to become
something that can be produced in kilograms.
Kilogram quantities! That's what you need for
clinical trials and eventually, if everything
goes well, for patients to actually use it. OK,
so that's the journey we're looking at. Yeah,
the journey. And it's not always a smooth one,
but it's full of clever solutions. And that's
what we're going to unpack today. So OPRD, that's
the brains and the actual work, I guess you could
say. Figuring out the absolute best way to make
a drug substance, the active ingredient, right?
The part that actually does what it's supposed
to do. Absolutely. And it's not just about discovering
it. It's about how you actually make it. Like,
how do you design a manufacturing process that's
reliable, that you can scale up? And that's where
the real challenges come in, you know? What works
perfectly fine in a little flask in a research
lab, it might completely fall apart when you
try to scale it up to these giant industrial
reactors. So you gotta problem solve. And that
leads to some really innovative chemistry and
engineering. We're actually looking at a specific
case study. from the literature where we can
see all of this unfold. The challenges, the troubleshooting,
all the clever tweets they had to make to the
process, it's all documented. Okay, so let's
get into this case then. All right. So the goal
at the beginning, it was pretty straightforward,
at least on the surface. They wanted to produce
kilograms of this pretty complex molecule. Yeah.
And obviously they weren't doing this just for
kicks, right? This was a crucial step to get
enough of this material to see if it could actually
work as a medicine in clinical trials. So the
stakes are pretty high. Absolutely. Yeah. So
they had to start somewhere. And they started
with an initial synthetic route, basically a
step -by -step recipe for building this molecule,
chemically speaking. Right. And in this case,
the original recipe was pretty involved. It was.
It was quite lengthy. Lots of individual steps.
And each one required specific conditions, specific
temperatures, maybe a catalyst. Yeah. a lot of
times they'd end up with these intermediate compounds
that they had to isolate and purify before moving
on to the next step. Yeah, it's like a really
complicated Lego set, you know? Like you have
all these separate stages and you got to do them
in the right order. Right, right. And if you
mess up one piece, well, the whole thing might
fall apart. So there's this one early hurdle
they came across, and it really shows just how
much detail goes into problem solving in this
kind of work. They needed to do this very specific
chemical transformation. called the reduction
of an aryl ketone to a methylene compound. Now,
I know that sounds like a whole lot of jargon,
but imagine trying to remove a very specific
type of connector from a complex structure. You
have all these different tools you could use,
and some are gonna be way more effective than
others. And some might even damage the parts
around the one you're trying to remove. Right,
exactly. And in chemistry, there are actually
a bunch of different tools or methods you can
use for this kind of reduction. OK. You've got
things like the Clemenson reduction, the Wolf
-Kishner reduction. You could even use hydrogen
gas with a catalyst or try a combination of other
chemicals. And they all have their pros and cons
depending on what specific molecule you're working
with. So finding the right method or optimizing
the one you've already got. That's a big part
of the challenge. So in this case, their initial
approach for that reduction step, it involved
using two really strong acids together, trifluoroacetic
acid and sulfuric acid. Now, on paper, this might
have seemed like a pretty straightforward way
to do it, maybe even a shortcut, but when they
actually tried it in the lab, Different story.
Yeah, it turned out to be much more difficult
than they thought. This acid mixture ended up
being incredibly corrosive, like way more than
they expected. It was a real problem. It's like
using a tool that's way too harsh for the job.
Yeah, it can damage the parts you want to keep.
And on top of that, they were getting a really
low yield of the molecule they wanted. Right.
Which is a big problem when you're trying to
manufacture something, right? It is. Low yield
basically means you're not getting enough of
your product at the end of the reaction. OK,
so it's inefficient. Very inefficient. It's like
baking a batch of cookies and only half of them
come out edible. Right. You've wasted a bunch
of ingredients and a lot of time, and you don't
have enough of what you actually wanted. Makes
sense. So that low yield with the corrosive acids,
that was a big red flag. It was a clear sign
that they needed to either find a way to make
that specific step. way more efficient or come
up with a whole new approach for that part of
the molecule. So they first tried to optimize
the route they already had, figure out if they
could tweak the conditions, maybe change the
temperature, the amount of acid they were using,
the timing of the reaction, stuff like that,
just to see if they could improve that problematic
reduction step and get a better overall result.
But they also had this other strategy they were
using to boost efficiency called telescoping.
telescoping steps. Now, and I got to clarify,
we're not talking about astronomy here. No, no,
not looking at stars. So in chemistry, telescoping
is kind of like streamlining a production line.
Right. Like in a factory. It means taking multiple
steps in the chemical synthesis and smooshing
them together, basically. Yeah, combining them.
So you end up with this single continuous process
and you don't have to isolate and purify the
intermediate products between each step. So it's
like fewer stops, fewer transfers, saves a ton
of time and resources. It's kind of like, instead
of building a car by first assembling the engine,
then moving it to another station to put on the
wheels and so on, you just try to do as much
of the assembly as you can all at once. Yeah,
that's a great analogy. So there are a few good
examples of this in this case study. They realized
they didn't actually need to isolate this one
intermediate molecule in an entridal derivative.
Right. And just by changing the solvent they
were using for that reaction, switching from
dimethylformamide to dichloromethane, they could
go straight to the next step without any purification
in between. Yeah, just like that. Just a solvent
switch. Yeah. And it made a big difference. Got
rid of a whole unit operation, made the process
simpler, and they had to handle less material
overall. Makes sense. Another cool example was
with this reaction called Mitsunobu reaction.
OK. It's a pretty common reaction, but usually
you'd have to purify the product afterwards.
Right. But in this case, they did something clever.
They followed the Mitsunobu reaction directly
with a biphasic hydrolysis. It basically means
they used two liquid layers that don't mix. OK.
And after they neutralized the whole mixture,
they could just pull the amino acid they wanted
straight out of the water layer. They didn't
need any chromatographic purification. at all.
And avoiding chromatography, that's a pretty
big deal, right? It is. I always picture chromatography
as these huge complicated machines. Yeah, they
can be. It seems like it would really slow things
down if you're trying to produce things on a
large scale. Oh, absolutely. While chromatography
is great for purification, it can be super time
consuming and expensive. Yeah. And it doesn't
always scale up well to industrial levels. So
if you can avoid it, especially when you're manufacturing
large quantities, that's a huge win. It saves
time and money. Yeah, I can see that. Makes the
whole process much more efficient. So it seems
like they were making good progress with these
telescoping steps. They were, yeah. Making the
whole thing more streamlined. But if I remember
correctly, They were still stuck on that aryl
ketone reduction. Oh, yeah. That one was a real
headache. It was like this one stubborn problem
they just couldn't shake. Even with all the other
improvements, that step with the strong acid
mixture was still giving them trouble. Low yields,
corrosion, the whole nine yards. It's funny,
isn't it? Like, you think you've got this well
-defined process, but then one tiny step can
just throw everything off when you try to scale
things up. It happens all the time. And that's
where the real detective work of OPRND comes
in. You've got to identify the problem areas
and then figure out how to fix them. Sometimes
it's a small tweak, sometimes you've got to completely
rethink your approach. And that's why this whole
process development thing is so important to
the pharmaceutical industry. It's crucial. It's
not enough to just know how to make a molecule
in a tiny little lab vial. Nope. You need a process
that's robust, reliable, and scalable. something
that can churn out high quality material in the
quantities you need for clinical trials, and
then eventually for the patients who need the
medicine. You're basically translating a scientific
discovery into something real, something that
can actually help people. Exactly. So what we've
seen here is a real life example of just how
complicated it can be to manufacture a complex
molecule, especially when you're trying to go
from milligrams to kilograms. It's a huge jump.
Yeah. And we saw how they use telescoping to
combine and simplify steps, which made the whole
thing more efficient. And they even managed to
avoid some of those tricky purification steps.
like chromatography. Right, but then you have
those stubborn challenges like the aryl ketone
reduction where the original method just didn't
work at scale. Yeah, and that's a good reminder
that process development is an ongoing thing.
Oh, absolutely. It never really stops. It's a
cycle of finding problems, investigating them,
and then tweaking and improving the process based
on what you learn. It's all about learning and
adapting. And it really makes you appreciate
all the work that goes into making a single pill.
It does. It's easy to forget that behind that
tiny tablet, there's a whole team of people who've
poured their expertise into making it a reality.
Chemists, engineers, analytical scientists, they're
all working together to figure out how to manufacture
these medicines. It's a huge collaborative effort.
And it's just as important as the initial discovery
of the drug itself. Absolutely. So something
to think about. Next time you see a pill, think
about all the hidden obstacles and clever solutions
that went into making it. Yeah, all those unseen
challenges. And if you're interested in learning
more, definitely check out the field of pharmaceutical
process chemistry and OPRND. Yeah, it's a fascinating
area where science and engineering meet to solve
real -world problems, and it leads to medicines
that can actually make people's lives better.
Couldn't have said it better myself. Amazing
stuff.